Sign in to fuzzto save your conversations, follow your research and come back anytime.
Max Healthcare Institute
SectorHealthcare
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Max Healthcare has two strategic business units: Max Lab, which provides diagnostic services outside its hospital network, and Max@Home, offering health and wellness services at home. The company is listed on the BSE and NSE, with Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. as its current promoters.
In the news
SC questions drug price caps beyond cancer medicines, pharma stocks fall
Vedanta, IDFC First Bank, Max Healthcare: Expert Stock Picks
Nifty Hits Fresh Five-Month Low at 23,118 as FII Selling Continues
Max Healthcare adds 400 beds, plans 1,800-bed Saket campus expansion
Max Healthcare unit faces ₹166 cr GST notice over fees
Delhi Master Plan 2047 boosts Max, Fortis, Medanta stocks
Max Healthcare shares fall 2.47% to ₹988.30 despite strong Q1 results
Max Healthcare shares fall 2.14% despite strong financial growth
Max Healthcare shares fall 2.62% despite strong Q4 results
RailTel Secures ₹107.60 Cr Order from Mahanadi Coalfields
Noida Healthcare Demand Outstrips Supply, MOFSL Prefers Medanta
Max Healthcare Gets 'Hold' Rating Despite 4,000 Bed Expansion Plans
Max Healthcare shares surge 6.58% on Citi buy rating
Top stocks to watch: JK Cement, ONGC, Fortis Healthcare
Max Healthcare: Strong long-term growth vs near-term headwinds
Max Healthcare Q4 profit up 3% to ₹387 cr; margin expansion masks growth concerns
SENSEX rises 232 points, NIFTY50 up 65 points on May 22
Max Healthcare shares drop 7% on Q4 earnings miss
Max Healthcare shares fall 7% as Q4 results miss estimates
Max Healthcare shares drop 7% on Q4 results despite 7% profit growth
The Quarter story
The two most recent quarterly results, compared side-by-side.
Max Healthcare drives strong revenue and EBITDA growth through network expansion, though rising debt and input costs require monitoring.
Gross revenue grew from ₹2,574 Cr to ₹2,982 Cr from Q1 FY26 to Q1 FY27 — confirming robust top-line expansion.
Net debt climbed from ₹1,755 Cr to ₹2,384 Cr from Q1 FY26 to Q1 FY27 — signaling increased leverage.
Operating EBITDA rose from ₹613 Cr to ₹704 Cr from Q1 FY26 to Q1 FY27 — demonstrating consistent operational profitability.
Finance costs rose from ₹34 Cr to ₹61 Cr from Q1 FY26 to Q1 FY27 — highlighting rising debt servicing pressure.
Max Lab pick-up points expanded from 700 to 890 from Q1 FY26 to Q1 FY27 — highlighting aggressive last-mile network growth.
Direct costs surged from ₹1,015 Cr to ₹1,179 Cr from Q1 FY26 to Q1 FY27 — indicating higher input consumption.
Operational bed capacity increased from 5,200 to 6,000 from Q2 FY26 to Q4 FY26 — signaling successful infrastructure scaling.
Effective tax rate increased from 21.8% to 24.4% from Q1 FY26 to Q1 FY27 — signaling a higher tax burden.
Monthly active users grew from 113.7 Mn to 123.5 Mn from Q1 FY26 to Q1 FY27 — indicating steady digital engagement.
Indirect overheads jumped from ₹831 Cr to ₹951 Cr from Q1 FY26 to Q1 FY27 — reflecting elevated administrative spending.
Company insights, generated from the most recent coverage.
Max is pushing renewals for a hoped-for increase plus a 6% automatic escalator, and engaging the insurer regulator on a CII-linked annual uplift — contractual indexation is the defence against administered rates.
Management puts price alone at roughly 6-7% of revenue growth even with zero bed-day growth. Caps attack the single largest lever in the ARPOB model.
In 2025 Star Health, Niva Bupa, Tata AIG and Care Health suspended cashless at Max's hospitals over tariff disputes. Max had to negotiate rather than dictate terms — scale did not win the standoff.